Health
Does the AstraZeneca vaccine have a future? – Financial Times
Hit by a multibillion-euro lawsuit and rare side-effects, the jab that was going to save the world has an uncertain outlook
On March 15, consultant haematologist Sue Pavord saw a patient who had recently received the Oxford/AstraZeneca Covid-19 vaccine.
The young man presented with serious and almost contradictory symptoms: a severe blood clot coupled with very low platelets, fragments of cells that help the blood clot.
“It’s common to have those things separately but as a linked combination it’s very unusual,” said Pavord, who is also a lecturer at Oxford university.
Pavord had spent time in Canada in the 1990s researching…
Continue Reading
